Can-Fite Biopharma Ltd - ADR

ASE:CANF

2.28

-0.05 (-2.15%)

Market Cap (Intraday)	38.35M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.22 Million
Adjusted EPS	-$0.11

See more estimates

10-Day MA	$2.28
50-Day MA	$2.16
200-Day MA	$2.03

See more pivots

Can-Fite Biopharma Ltd - ADR Stock, ASE:CANF

10 Bareket Street, Kiryat Matalon, Petach Tikva, HaMerkaz 49170

Israel

Phone: +972.3.924.1114

Number of Employees: 8

http://www.canfite.com

Description

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for cancer and inflammatory diseases. Its product pipeline includes Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.